Education
About Us
Working with TipRanks
Follow Us
GNCC Capital (GNCP)
:GNCP
GNCP Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
GNCP FAQ
What was GNCC Capital ’s price range in the past 12 months?
Currently, no data Available
What is GNCC Capital ’s market cap?
GNCC Capital ’s market cap is $174.15K.
When is GNCC Capital ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GNCC Capital ’s earnings last quarter?
GNCC Capital released its earnings results on Apr 12, 2021. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is GNCC Capital overvalued?
According to Wall Street analysts GNCC Capital ’s price is currently Overvalued.
Does GNCC Capital pay dividends?
GNCC Capital does not currently pay dividends.
What is GNCC Capital ’s EPS estimate?
GNCC Capital ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GNCC Capital have?
GNCC Capital has 174,144,780,000 shares outstanding.
What happened to GNCC Capital ’s price movement after its last earnings report?
GNCC Capital reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of GNCC Capital ?
Currently, no hedge funds are holding shares in GNCP
---
Company Description
GNCC Capital
GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.
---
Marijuana Company of America
―
Cannabis Sativa
―
Medical Marijuana
―
Hemp
―
CNBX Pharmaceuticals
―
---